NCT00335101View on ClinicalTrials.gov

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2006

Conditions
Coronary Artery Disease (CAD)Renal ImpairmentDiabetes Mellitus
Interventions
DRUG

Iodixanol, Ioversol, Iopromide

Trial Locations (2)

80807

GE Healthcare, Munich

08540

GE Healthcare, Princeton

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY